Covid: Under-30s offered alternative to AstraZeneca jab

Under-30s are to be offered an alternative Covid jab to the AstraZeneca vaccine due to mounting evidence linking it to rare blood clots, the UK’s vaccine advisory body says. The regulator said this was not proof the jab had caused the clots. via Technology and News Today https://www.bbc.com/news/health-56665517

Have people died after getting vaccinated? Can the vaccine help with lingering side effects?

People still have a lot of questions about the COVID-19 vaccines. Local 4′s Dr. Frank McGeorge is working to answer as many as possible. Unfortunately, the answer is no. We aren’t completely sure what factors are involved in some people having prolonged symptoms of a coronavirus infection. via Technology and News Today https://www.clickondetroit.com/health/good-health/2021/03/03/have-people-died-after-getting-vaccinated-can-the-vaccine-help-with-lingering-side-effects/

Johnson & Johnson’s single-shot vaccine is effective, FDA confirms

The one-dose COVID-19 vaccine made by Johnson & Johnson protects against severe disease and has no serious safety concerns, according to a new analysis published today by the US Food and Drug Administration. via Technology and News Today https://www.theverge.com/2021/2/24/22298855/covid-vaccine-johnson-effective-fda-south-africa-variant

Vaccines Alone Are Not Enough to Beat COVID

Vaccines Alone Are Not Enough to Beat COVID

The world’s attention is rightly focused on news of COVID-19 vaccine updates, from eligibility to supply. But we will make a critical error if we ignore the need for treatments as well as vaccines. Vaccines may not reach everyone for many years. Vaccines will not protect everyone.

Continue Reading . . . https://www.scientificamerican.com/article/vaccines-alone-are-not-enough-to-beat-covid/

The Second-Generation COVID Vaccines Are Coming

The Second-Generation COVID Vaccines Are Coming

Six months ago, as the northern hemisphere was still battling the coronavirus pandemic’s first wave, all eyes turned to the COVID-19 vaccines in late-stage clinical trials. Now, a year after the pandemic first erupted, three COVID vaccines have been given emergency authorization by either the U.S.

Continue Reading . . . https://www.scientificamerican.com/article/the-second-generation-covid-vaccines-are-coming/

COVID-19 Vaccine Developers Search for Antibodies That ‘First Do No Harm’

COVID-19 Vaccine Developers Search for Antibodies That ‘First Do No Harm’
The coronavirus pandemic has provided the world with a quick study in the intricacies of immunology. “Herd immunity” and “serological tests” have become household terms. Front and center among these concepts are antibodies.
Continue reading … https://ift.tt/3d99dQU

Coronavirus Vaccine Trials Have Delivered Their First Results—But Their Promise is Still Unclear

Coronavirus Vaccine Trials Have Delivered Their First Results—But Their Promise is Still Unclear
As coronavirus vaccines hurtle through development, scientists are getting their first look at data that hint at how welldifferent vaccines are likely to work. The picture, so far, is murky.
Continue reading … https://ift.tt/2zm6yVg